Hjem
Eva Birgitta Åsjøs bilde

Eva Birgitta Åsjø

Professor
  • E-postBirgitta.Asjo@uib.no
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • 2016. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. Clinical Infectious Diseases. 655-663.
  • 2016. The global spread of HIV-1 subtype B epidemic. Infection, Genetics and Evolution. 169-179.
  • 2015. Global dispersal pattern of HIV type 1 subtype CRF01-AE: A genetic trace of human mobility related to heterosexual sexual activities centralized in southeast Asia. Journal of Infectious Diseases. 1735-1744.
  • 2014. Patterns of transmitted HIV drug resistance in Europe vary by risk group. PLOS ONE.
  • 2014. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infectious Diseases.
  • 2013. Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology. 10 sider.
  • 2013. HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology. 13 sider.
  • 2012. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology. 13 sider.
  • 2012. Counting mycobacteria in infected human cells and mouse tissue: a comparison between qPCR and CFU. PLOS ONE. 11 sider.
  • 2011. Increased intracellular growth of Mycobacterium avium in HIV-1 exposed monocyte-derived dendritic cells. Microbes and infection. 276-283.
  • 2010. Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages. Infection and Immunity. 4022-4032.
  • 2009. Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe. Journal of Infectious Diseases. 1503-1508.
  • 2009. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology. 11 sider.
  • 2009. The hepatitis C virus enigma. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 427-439.
  • 2009. HIV Induces both a Down-Regulation of IRAK-4 that Impairs TLR Signalling and an Up-regulation of the Antibiotic Peptide Dermcidin in Monocytic Cells. Scandinavian Journal of Immunology. 264-276.
  • 2008. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS (London). 625-635.
  • 2008. Real-time quantitative PCR in the diagnosis of tuberculosis in formalin-fixed paraffin-embedded pleural tissue in patients from a high HIV endemic area. Diagnostic molecular pathology (Print). 112-117.
  • 2006. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. Journal of Acquired Immune Deficiency Syndromes. 352-360.
  • 2006. Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 277-284.
  • 2005. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. Journal of Infectious Diseases. 958-966.
  • 2005. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). Journal of Clinical Virology. 211-215.
  • 2004. Updated European recommendations for the clinical use of HIV drug resistance testing. Antiviral Therapy. 829-848.
  • 2004. Relevance of a combined HIV antigen/antibody assay to detect early HIV infection in a low prevalence population: Case reports. Clinical Laboratory. 409-413.
  • 2004. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clinical and Laboratory Immunology. 29-34.
  • 2004. Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway. Scandinavian Journal of Immunology. 203-208.
  • 2004. An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy. HIV Medicine. 400-406.
  • 2003. Changes in Immunoglobulin isotypes and Immunoglobulin G (IgG) subclasses during Highly Active Antiretroviral Therapy. Anti-p24 IgG1 closely parallells the biphasic decline in plasma viremia. Journal of Ascuired Immune Deficiency Syndrome. 358-367.
  • 2002. Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral Therapy. AIDS Research and Human Retroviruses. 1357-1365.
  • 2001. The Fas/FasL System and T Cell Apoptosis in HIV-1-Infected Lymphoid Tissue during Highly Active Antiretroviral Therapy. Clinical Immunology. 169-179.
  • 2001. Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization. AIDS Research and Human Retroviruses. 577-586.
  • 2001. HIV-1 resistens mot antiretrovirale midler. Tidsskrift for Den norske legeforening. 3421-3424.
  • 2000. V3 sequence analysis and biological characterization of HIV-1 isolates from asymptomatic and early symptomatic Tanzanian individuals. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 608-616.
  • 2000. Normalization of CD4+ Cell Numbers and Reduced Levels of Memory CD8+ Cells in Blood and Tonsillar Tissue after Highly Active Antiretroviral Therapy in Early HIV Type-1 Infection. AIDS Research and Human Retroviruses. 191-201.
  • 2000. Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. AIDS Research and Human Retroviruses. 49-58.
  • 2000. Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children. AIDS Research and Human Retroviruses. 327-336.
  • 2000. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific heterophile antibodies. Clinical and Laboratory Immunology. 451-456.
  • 2000. Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals. Scandinavian Journal of Immunology. 195-201.
  • 2000. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region. AIDS Research and Human Retroviruses. 867-870.
  • 2000. Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 539-550.
  • 1999. Transient Tat activation of the HIVLAV/Lai-1 LTR by primary HIV-1 phenotypic variants in HeLaT4LTR_b-gal cells. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 485-492.
  • 1999. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. AIDS (London). 2365-2376.
Rapport
  • 2013. Usage of antivirals and the occurrence of antiviral resistance in Norway 2011-2012. 2013:5. 2013:5. .
  • 1998. HIV-infeksjon, en strategirapport. .
Populærvitenskapelig artikkel
  • 2005. HIV-gåtan och nya virus. P2-Akademiet. 165-175.
Brev til redaktøren
  • 2004. Locking the door to HIV entry: how far can we go? AIDS (London). 2197-2198.
Intervju
  • 2005. Intervju med anledning av Nelson Mandelas besök och HIV-situationen i Afrika.
  • 2005. Intervju i Vert å Vite om nya virus.
  • 2005. Intervju i Vert å Vite om HIV och bushmeat.
  • 2005. Intervju i Dagsnytt 18 om HIV-resistens, Svartedauen och selektion av mutation.
  • 2005. Fight AIDS @ home.
  • 2005. Fight AIDS @ home.
  • 2005. Biodiversitet och nya virus.
Programdeltagelse
  • 2005. HIV-gåtan och nya virus.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • 1998. Mikrobiologisk diagnostikk. Kapittel om Nukleinsyrebasert diagnostikk.
Sammendrag/abstract
  • 2006. Transmission of drug-resistance in Europe is characterized by single mutations and revertants. Antiviral Therapy. S111-S111.
Poster
  • 2008. Rapid and reliable quantification of mycobacteria inside macrophages in vitro and mice using real-time quantitative PCR.
  • 2008. Rapid and reliable quantification of Mycobacteria inside macrophages in vitro and mice mice using real-taime quantitative PCR.
  • 2006. Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection.
  • 2005. Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection.
Vitenskapelig oversiktsartikkel/review
  • 2008. Medikamentell resistens vid HIV-infektion. 2593-2596.

Se fullstendig oversikt over publikasjoner i CRIStin.

Forskergrupper